| 1 |
32064171 | Peptides containing the MXXCW motif inhibit oncogenic RET kinase activity with a novel mechanism of action. | 2020 |
3 |
| 2 |
26780347 | Commentary to Gorelenkova Miller and Mieyal (2015): sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases. | 2016 Apr |
1 |
| 3 |
20235151 | A redox-linked novel pathway for arsenic-mediated RET tyrosine kinase activation. | 2010 May 15 |
3 |
| 4 |
16732321 | Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations. | 2006 Nov 9 |
2 |
| 5 |
14715928 | Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease. | 2004 Apr |
1 |
| 6 |
11121408 | Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins. | 2001 Mar 23 |
2 |
| 7 |
11491658 | Osmotic stress-mediated activation of RET kinases involves intracellular disulfide-bonded dimer formation. | 2001 Jun |
4 |
| 8 |
10637293 | Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases. | 2000 Jan |
5 |
| 9 |
11213488 | Molecular mechanism of activation and superactivation of Ret tyrosine kinases by ultraviolet light irradiation. | 2000 Winter |
9 |
| 10 |
10049754 | Mechanism of Ret activation by a mutation at aspartic acid 631 identified in sporadic pheochromocytoma. | 1999 Feb 24 |
3 |
| 11 |
9502784 | Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease. | 1998 Mar 15 |
2 |
| 12 |
9620546 | Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation. | 1998 May 7 |
1 |
| 13 |
9879991 | Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines. | 1998 Dec 3 |
1 |
| 14 |
10027003 | Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations. | 1998 |
3 |
| 15 |
9012462 | The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. | 1997 Feb 1 |
1 |
| 16 |
9242375 | Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain. | 1997 Jul 24 |
2 |
| 17 |
8561803 | Detection of ret homodimers in MEN 2A-associated pheochromocytomas. | 1996 Jan 17 |
1 |
| 18 |
7532281 | Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. | 1995 Mar |
1 |
| 19 |
8573606 | Oncogenic activation of the ret protooncogene in thyroid cancer. | 1995 |
2 |